More information
restricted area

Life Sciences

Currently, Biotechnology is an area of ??strong industrial application and Brazil occupies the 5th place among the countries that most generate jobs in this sector ( Source: ). The use of biotechnology for agricultural production accounts for about 40% of the Brazilian GDP. In addition, the country stands out internationally for the generation of wealth from components of native biodiversity, which results in great potential for research and development of new products and medicines for society. The BPH proposal is to promote alignment among national and international regulatory agencies to lower regulatory barriers between Brazil and target countries to attract more private investments in infrastructure and R & D for Brazilian biopharmaceutical companies. The BPH carries out actions that cause impacts on regulatory aspects, foreign trade, partnership for the development of new business, attraction of direct investment companies among others. Check the actions programmed and in case of doubt, contact us!

Seu e-mail foi cadastrado com sucesso!


Stay on top of what happens in the pharmaceutical market.